Cytokinetics, Incorporated · NASDAQ:CYTK
Henderson John T sold 20,000 Cytokinetics, Incorporated shares (Form 4)
Traded May 5, 2026 · Filed May 5, 2026
On May 5, 2026, Henderson John T (Director) sold 20,000 Cytokinetics, Incorporated shares at US$75.97 for US$1.52M under a trading plan, leaving 75,237 shares. Filed May 5, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$75.97
- Value
- US$1.52M
- Holding after
- 75,237 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Option exercise | 20,000 | US$7.61 | 95,237 | Direct |
| May 5, 2026 | Common Stock | Sale | 20,000 | US$75.97 | 75,237 | Direct |
Source
Related
- Cytokinetics, Incorporated
- Henderson John T
- Cytokinetics, Incorporated shareholders
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Henderson John T · Jul 16, 2026
- Form 4 · Henderson John T · May 27, 2026
- Form 4 · Henderson John T · Apr 15, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026
- Form 4 · Kaye Edward M. MD · Oct 20, 2026